Simulations Plus EBITDA Margin 2010-2024 | SLP
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Simulations Plus (SLP) over the last 10 years. The current EBITDA margin for Simulations Plus as of August 31, 2024 is .
| Simulations Plus EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-08-31 |
$0.07B |
$0.01B |
15.49% |
| 2024-05-31 |
$0.07B |
$0.01B |
14.71% |
| 2024-02-29 |
$0.07B |
$0.01B |
18.46% |
| 2023-11-30 |
$0.06B |
$0.01B |
19.05% |
| 2023-08-31 |
$0.06B |
$0.01B |
20.00% |
| 2023-05-31 |
$0.06B |
$0.01B |
25.00% |
| 2023-02-28 |
$0.06B |
$0.02B |
27.27% |
| 2022-11-30 |
$0.05B |
$0.02B |
31.48% |
| 2022-08-31 |
$0.05B |
$0.02B |
37.04% |
| 2022-05-31 |
$0.05B |
$0.02B |
38.46% |
| 2022-02-28 |
$0.05B |
$0.02B |
40.00% |
| 2021-11-30 |
$0.05B |
$0.02B |
37.50% |
| 2021-08-31 |
$0.05B |
$0.02B |
38.30% |
| 2021-05-31 |
$0.05B |
$0.02B |
40.43% |
| 2021-02-28 |
$0.05B |
$0.02B |
39.13% |
| 2020-11-30 |
$0.04B |
$0.02B |
39.53% |
| 2020-08-31 |
$0.04B |
$0.02B |
36.59% |
| 2020-05-31 |
$0.04B |
$0.02B |
38.46% |
| 2020-02-29 |
$0.04B |
$0.02B |
40.54% |
| 2019-11-30 |
$0.04B |
$0.01B |
40.00% |
| 2019-08-31 |
$0.03B |
$0.01B |
41.18% |
| 2019-05-31 |
$0.03B |
$0.01B |
42.42% |
| 2019-02-28 |
$0.03B |
$0.01B |
40.63% |
| 2018-11-30 |
$0.03B |
$0.01B |
41.94% |
| 2018-08-31 |
$0.03B |
$0.01B |
43.33% |
| 2018-05-31 |
$0.03B |
$0.01B |
41.38% |
| 2018-02-28 |
$0.03B |
$0.01B |
44.44% |
| 2017-11-30 |
$0.03B |
$0.01B |
42.31% |
| 2017-08-31 |
$0.02B |
$0.01B |
41.67% |
| 2017-05-31 |
$0.02B |
$0.01B |
40.91% |
| 2017-02-28 |
$0.02B |
$0.01B |
38.10% |
| 2016-11-30 |
$0.02B |
$0.01B |
40.00% |
| 2016-08-31 |
$0.02B |
$0.01B |
40.00% |
| 2016-05-31 |
$0.02B |
$0.01B |
40.00% |
| 2016-02-29 |
$0.02B |
$0.01B |
40.00% |
| 2015-11-30 |
$0.02B |
$0.01B |
40.00% |
| 2015-08-31 |
$0.02B |
$0.01B |
36.84% |
| 2015-05-31 |
$0.02B |
$0.01B |
41.18% |
| 2015-02-28 |
$0.02B |
$0.01B |
40.00% |
| 2014-11-30 |
$0.01B |
$0.01B |
38.46% |
| 2014-08-31 |
$0.01B |
$0.01B |
41.67% |
| 2014-05-31 |
$0.01B |
$0.00B |
33.33% |
| 2014-02-28 |
$0.01B |
$0.00B |
36.36% |
| 2013-11-30 |
$0.01B |
$0.01B |
45.45% |
| 2013-08-31 |
$0.01B |
$0.01B |
50.00% |
| 2013-05-31 |
$0.01B |
$0.01B |
50.00% |
| 2013-02-28 |
$0.01B |
$0.00B |
40.00% |
| 2012-11-30 |
$0.01B |
$0.00B |
30.00% |
| 2012-08-31 |
$0.01B |
$0.00B |
30.00% |
| 2012-05-31 |
$0.01B |
$0.00B |
40.00% |
| 2012-02-29 |
$0.01B |
$0.00B |
40.00% |
| 2011-11-30 |
$0.01B |
$0.00B |
40.00% |
| 2011-08-31 |
$0.01B |
$0.00B |
40.00% |
| 2011-05-31 |
$0.01B |
$0.00B |
30.00% |
| 2011-02-28 |
$0.01B |
$0.00B |
30.00% |
| 2010-11-30 |
$0.01B |
$0.00B |
30.00% |
| 2010-08-31 |
$0.01B |
$0.00B |
30.00% |
| 2010-05-31 |
$0.01B |
$0.00B |
30.00% |
| 2010-02-28 |
$0.01B |
$0.00B |
30.00% |
| 2009-11-30 |
$0.01B |
$0.00B |
33.33% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.629B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
